Company Search:
Advanced Search
Sponsored Links
Morphosys AG - ADR Company Snapshot
Morphosys AG - ADR operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Morphosys AG - ADR with three other companies in this sector in the United States: Aduro Biotech Inc (2016 sales of $50.68 million of which 100% was ), Reata Pharmaceuticals Inc ($49.86 million of which 100% was Pharmaceutical), and Luna Innovations Incorporated ($59.21 million ).

Sales Analysis. During the year ended December of 2016, sales at Morphosys AG - ADR were $54.90 million. This is a sharp decrease of 53.1% versus 2015, when the company's sales were $117.16 million. Contributing to the drop in overall sales was the 99.0% decline in Proprietary Development, from $66.11 million to $685,416.33 . . However, these declines were partially offset by the increase in sales of Partnered Discovery (up 6.2% to $54.22 million) .
  Stock Performance Chart for Morphosys AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/11/2018): 51.50
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks 17.8%  
4 Weeks 17.2%   52 Weeks 100.5%  
Morphosys AG - ADR Key Data:
  Ticker: MPSY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 54,903,410
(Year Ending Jan 2017).
Employees: 345
  Currency: U.S. Dollars Market Cap: 2,989,118,298
  Fiscal Yr Ends: December Shares Outstanding: 58,041,132
  Share Type: Stammaktie Closely Held Shares: 1,369,884
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.